Lv1
40 积分 2025-12-29 加入
In vivo CAR T cell generation to treat cancer and autoimmune disease
4天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
4天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
12天前
已完结
CAR-T cell therapy for autoimmune diseases: from immune suppression to immune resetting
1个月前
已完结
Leveraging chimeric antigen receptor–T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology
1个月前
已完结
CAR-based cellular therapies for autoimmune diseases: immune reset, clinical evidence, and translational boundaries
1个月前
已完结
Multiple Sclerosis Onset Preceding Epstein-Barr Virus Infection
1个月前
已完结
The Pharmacology of CAR T Cell Therapy for Autoimmune Disease
1个月前
已完结
The landscape of genetic medicines for in vivo T cell reprogramming
1个月前
已完结
Adoptive T-cell therapies in neuroinfectious and neuroinflammatory diseases
1个月前
已完结
Screening of shared molecular markers between cervical cancer and major depressive disorder and the mechanism of CRAT/CLIC4 regulating EMT in cervical cancer cells
皖公网安备34019202002308
